Literature DB >> 6277918

Neutrophil-mediated methemoglobin formation in the erythrocyte. The role of superoxide and hydrogen peroxide.

S J Weiss.   

Abstract

Human neutrophils incubated with phorbol myristate acetate oxidized hemoglobin within the intact erythrocyte by a mechanism dependent on cell-cell contact but independent of phagocytosis. Spectrophotometric examination of the erythrocyte lysates revealed that the major component formed was methemoglobin along with small amounts of a species with spectral characteristics similar to choleglobin. Methemoglobin formation was directly related to the neutrophil concentration and the time of incubation. The addition of superoxide dismutase or catalase modestly inhibited the formation of methemoglobin, while a combination of the enzymes provided the most dramatic protection. Methemoglobin of hydroxyl radical or hypochlorous acid scavengers. Apparently, either O2.- or H2O2 alone was capable of mediating methemoglobin formation in the intact erythrocyte. Maintenance of the intraerythrocytic hemoglobin in its oxygenated state or its derivatization to carbon monoxyhemoglobin markedly inhibited methemoglobin formation. Blockade of the anion channels in the intact erythrocyte with sulfonated stilbenes inhibited O2.- but not H2O2 from oxidizing intracellular hemoglobin. It appears that neutrophil-derived O2.- and H2O2 can cross the erythrocyte membrane through the anion channel or diffuse directly into the intracellular space and react with oxyhemoglobin or deoxyhemoglobin to form a mixture of hemoglobin oxidation products within the intact cell.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6277918

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  Methemoglobin is a supplement for in vitro culture of human nasopharyngeal epithelial cells transformed by human papillomavirus type 16 DNA.

Authors:  W N Wen
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001 Nov-Dec       Impact factor: 2.416

2.  Superoxide dismutase and Glutathione peroxidase in the blood of dogs with Leishmaniasis.

Authors:  D Britti; S Sconza; V M Morittu; D Santori; A Boari
Journal:  Vet Res Commun       Date:  2008-09       Impact factor: 2.459

Review 3.  Mechanisms of oxidant-induced changes in erythrocytes.

Authors:  J R Hatherill; G O Till; P A Ward
Journal:  Agents Actions       Date:  1991-03

4.  Comparison of human red cell lysis by hypochlorous and hypobromous acids: insights into the mechanism of lysis.

Authors:  M C Vissers; A C Carr; A L Chapman
Journal:  Biochem J       Date:  1998-02-15       Impact factor: 3.857

5.  Ischemia-reperfusion in humans. Appearance of xanthine oxidase activity.

Authors:  H P Friedl; D J Smith; G O Till; P D Thomson; D S Louis; P A Ward
Journal:  Am J Pathol       Date:  1990-03       Impact factor: 4.307

6.  Thermal injury, intravascular hemolysis, and toxic oxygen products.

Authors:  J R Hatherill; G O Till; L H Bruner; P A Ward
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

7.  Lipid peroxidation and oxidation of several compounds by H2O2 activated metmyoglobin.

Authors:  J Kanner; S Harel
Journal:  Lipids       Date:  1985-09       Impact factor: 1.880

8.  Production of luminol-reactive oxygen radicals during Plasmodium vinckei infection.

Authors:  R Stocker; N H Hunt; I A Clark; M J Weidemann
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

9.  Antioxidant functions for the hemoglobin β93 cysteine residue in erythrocytes and in the vascular compartment in vivo.

Authors:  Dario A Vitturi; Chiao-Wang Sun; Victoria M Harper; Bessy Thrash-Williams; Nadiezhda Cantu-Medellin; Balu K Chacko; Ning Peng; Yanying Dai; J Michael Wyss; Tim Townes; Rakesh P Patel
Journal:  Free Radic Biol Med       Date:  2012-11-16       Impact factor: 7.376

10.  Role of oxygen radicals in tourniquet-related ischemia-reperfusion injury of human patients.

Authors:  H P Friedl; G O Till; O Trentz; P A Ward
Journal:  Klin Wochenschr       Date:  1991-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.